Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0I5VJ
|
|||
Former ID |
DNC006398
|
|||
Drug Name |
THIOGENISTEIN
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H10O4S
|
|||
Canonical SMILES |
C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=S)O)O)O
|
|||
InChI |
1S/C15H10O4S/c16-9-3-1-8(2-4-9)11-7-19-13-6-10(17)5-12(18)14(13)15(11)20/h1-7,16-18H
|
|||
InChIKey |
RPDMOSIZAIBSRV-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Estrogen receptor beta (ESR2) | Target Info | Inhibitor | [1] |
KEGG Pathway | Estrogen signaling pathway | |||
Prolactin signaling pathway | ||||
Pathway Interaction Database | Plasma membrane estrogen receptor signaling | |||
Validated nuclear estrogen receptor beta network | ||||
Validated nuclear estrogen receptor alpha network | ||||
Reactome | Nuclear Receptor transcription pathway | |||
WikiPathways | SIDS Susceptibility Pathways | |||
Ovarian Infertility Genes | ||||
Integrated Pancreatic Cancer Pathway | ||||
Nuclear Receptors |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators. J Med Chem. 2006 Apr 20;49(8):2440-55. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.